Skip to main content

Medical Policy Update: Chelation Therapy

Effective June 11, 2018, the guidelines of our medical policy, Chelation Therapy, will also be applied to claims for services provided to patients enrolled in Horizon Blue Cross Blue Shield of New Jersey Medicare Advantage (MA) plans.

Review the guidelines of our medical policy, Chelation Therapy, in our Medical Policy Manual


Based on the guidelines of our medical policy, Chelation Therapy, claims for services provided on and after June 11, 2018 to members enrolled in Horizon BCBSNJ MA plans will be processed as noted below.

  • HCPCS codes J0470 and/or J0895 may be denied, based on the submitted diagnosis code(s), as experimental/investigational services.

Unless Horizon BCBSNJ gives written notice that all or part of the above changes have been cancelled or postponed, the changes will be applied to claims on and after June 11, 2018.

Published on: May 9, 2018, 07:55 AM ET
Last updated on: May 9, 2018, 08:01 AM ET